Clinical trials
Heart Diseases trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 9 |
| Recruiting | 7 |
| Unknown status | 5 |
| Active, not recruiting | 5 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Silesian Centre for Heart Diseases | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Bayer | 2 |
| Cardurion Pharmaceuticals, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Sanofi | 2 |
| Weill Medical College of Cornell University | 2 |
| Abbott Medical Devices | 1 |
| Abcentra | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 52 |
| Cardiovascular Diseases | 21 |
| Heart Failure | 14 |
| Coronary Artery Disease | 8 |
| Acute Coronary Syndrome | 7 |
| Cardiomyopathies | 6 |
| Myocardial Infarction | 6 |
| Coronary Disease | 5 |
| Atherosclerosis | 4 |
| Atrial Fibrillation | 4 |
Trials
Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.